India News | Low Number of COVID-19 Cases Now as India Chose Right Vaccine, Says Serum Institute's Poonawalla

Pune, Apr 4 (PTI) Serum Institute of India CEO Adar Poonawalla on Monday said the low number of COVID-19 cases at the moment was because the country chose the right vaccine.

Also Read | Delhi Police Arrest 3 Contract Killers Involved in Murder Case Using Dump Data Analysis Technique.

Speaking to reporters on the sidelines of the 'Alternate Fuel Conclave', he said the fourth wave, if at all it occurs, will hopefully be mild.

Also Read | Turkey's Annual Inflation Hits Record High at 61.14%, Currency Lira Loses 60% Value Since 2021.

Speaking on the booster dose, he said, "About the booster dose, we have appealed to the government, because everyone who needs to travel, needs the booster dose. They (government) are having internal discussions and a policy on booster dose may be announced soon."

All other countries are doing it and it was now time for India to have a look at it (booster dose), Poonawalla said, adding that the Centre had done a fantastic job by covering most of eligible adult population with two vaccine doses.

"Our vaccines have proven better that those in other countries. Look at US, and Europe, they have a lot of cases. We have fewer cases because we chose the right vaccines," he said.

Queried on whether the vaccines in their current form work on new coronavirus variants, he said they will work only if a booster dose is taken, as this will form protection from future variants.

In India, experts are deciding on mixing vaccines though it is allowed the world over, Poonawalla added.

The Pune-based SII manufactures Covishield vaccine.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)